Humankind Investments’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
Other funds holding DGX
Humankind Investments's DGX Position: Q4 2025 in Review
Humankind Investments sold out of Quest Diagnostics (DGX) in Q4 2025, closing a stake of 6,452 shares — an estimated $1.23M sold.
Humankind Investments first reported a position in DGX in Q1 2021 and held it in 19 quarters. The position peaked at $1.23M in Q3 2025. 1,048 funds tracked by Wall St. Rank hold DGX as of Q4 2025.
- Humankind Investments reported no remaining Quest Diagnostics position as of Q4 2025 after selling out during the quarter.
- Humankind Investments sold 6,452 Quest Diagnostics shares in Q4 2025, an estimated $1.23M.
- Humankind Investments first reported a position in Quest Diagnostics in Q1 2021 and held it in 19 quarters.
- Humankind Investments's Quest Diagnostics position peaked at $1.23M in Q3 2025.
- 1,048 funds tracked by Wall St. Rank held Quest Diagnostics as of Q4 2025.
Based on Humankind Investments's 13F filing for Q4 2025, filed 17 Feb 2026.